Galderma

Pharma

Galderma doubles Nemluvio peak sales outlook to $4B-plus

The update follows what Galderma’s CEO described as an “outstanding launch trajectory” for the Dupixent competitor in its first full year on the market.

Angus Liu Mar 5, 2026 11:20am

Galderma plans to spend $650M on US-based manufacturing

Oct 23, 2025 11:18am

Galderma's itch relief claims scratched after Sanofi complaint

Oct 8, 2025 9:45am

A photo from Galdermas Scratch Resistance campaign showing a woman standing at the top of a pile of rulers

Galderma starts DTC campaign for eczema drug across TV, digital

Apr 22, 2025 10:55am

Organon's Vtama, Galderma's Nemluvio endorsed by FDA for eczema

Dec 16, 2024 9:00am

Traffic light go start restart green light

FDA approves Galderma's prurigo nodularis treatment Nemluvio

Aug 13, 2024 10:37am